Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study

• Alex J. Mitchell ,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: ajm80@le.ac.uk

  Affiliation University of Leicester, Leicester, England, United Kingdom

  http://orcid.org/0000-0001-6014-598X

  ⨯
• Davy Vancampfort,

  Roles Formal analysis, Visualization, Writing – original draft

  Affiliation University Psychiatric Center, Catholic University Leuven, Kortenberg, Belgium

  ⨯
• Peter Manu,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliations University Psychiatric Center, Kortenberg, Belgium, School of Mental Health and Neuroscience (EURON), University Medical Center, Maastricht, The Netherlands

  ⨯
• Christoph U. Correll,

  Roles Visualization, Writing – original draft

  Affiliations Zucker Hillside Hospital, Glen Oaks, New York, United States, Hofstra North Shore–LIJ School of Medicine, Hempstead, New York, United States

  ⨯
• Martien Wampers,

  Roles Data curation, Writing – original draft

  Affiliation University Psychiatric Center, Catholic University Leuven, Kortenberg, Belgium

  ⨯
• Ruud van Winkel,

  Roles Data curation, Writing – original draft

  Affiliation University Psychiatric Center, Catholic University Leuven, Kortenberg, Belgium

  ⨯
• Weiping Yu,

  Roles Data curation, Writing – original draft

  Affiliation University Psychiatric Center, Catholic University Leuven, Kortenberg, Belgium

  ⨯
• Marc De Hert

  Roles Data curation, Visualization, Writing – original draft

  Affiliation University Psychiatric Center, Catholic University Leuven, Kortenberg, Belgium

  ⨯